The Patent Finder
RM

Reverse Medical Corporation

First filing 2008
OverviewNotableFeesChangesPatent listSources & methods

0 patents currently held, every record listed here

9 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

This portfolio holds none of the 9 US patents in force on its record. from the record

Of the 9 now held by other companies, 9 name Covidien LP as their current owner. Each row says so.

Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
0
Ending by 2030
none
Next term end

When these terms end

Each bar runs from grant to computed term end. 2012 to 2035.
US 8,343,167 Thrombectomy System and Method Sep 16, 2029
US 8,333,783 Occlusion Device and Method of Use Oct 8, 2029
US 8,641,777 Embolic Implant and Method of Use May 30, 2032
US 9,301,827 Embolic Implant and Method of Use May 30, 2032
US 8,808,361 Protuberant Aneurysm Bridging Device and Method of Use Oct 8, 2032
US 9,072,620 Protuberant Aneurysm Bridging Device Deployment Method Oct 8, 2032
US 9,241,815 Protuberant Aneurysm Bridging Device and Method of Use Oct 8, 2032
US 10,953,193 Microcatheter with Modified PTFE Liner Jun 30, 2034
US 9,694,201 Method of Use of an Embolic Implant for Radio-Ablative Treatment Jun 26, 2035
20172022202720322035
Every computed term in this portfolio is shown above.Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know

Notable patents

Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
None of the currently held patents qualifies as notable.

Formerly held, still cited

Notable
Cited by 183 later US patents, top 5% of utility patents granted in 2014 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2032.
now held by Covidien LP
Ends May 2032 · High confidence
Also notable
Cited by 281 later US patents, top 5% of utility patents granted in 2012 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2029.
now held by Covidien LP
Ends Oct 2029 · High confidence
Also notable
Cited by 37 later US patents, top 25% of utility patents granted in 2014 in our data, and renewed at 3 of 3 maintenance windows. Protection runs to 2032.
now held by Covidien LP
Ends Oct 2032 · High confidence

Fee deadlines

No maintenance fee falls due on this company's record before Nov 17, 2027.

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first.
Also on record: 9 patents in force now held by others · 5 patents ended · 1 application abandoned. List them

Sources and methods

Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited